capital fundSigvion was founded in 2004 to finance and support the life-saving and world-changing medicines of tomorrow, creating significant returns for our investors.
Founded in 2004
HQ60607 806 W. Washington St.
Sigvion Capital at CrunchBase
Sigvion Capital invested $41M in Akebia Therapeutics as a Series C round
Sigvion Capital invested $4.1M in Akebia Therapeutics as a Series B round
Sigvion Capital invested $22M in Akebia Therapeutics as a Series B round
Sigvion Capital invested $16M in Akebia Therapeutics as a Series A round
Sigvion Capital was founded in 2004